GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MyHealthChecked PLC (LSE:MHC) » Definitions » YoY EBITDA Growth

MyHealthChecked (LSE:MHC) YoY EBITDA Growth : -320.00% (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is MyHealthChecked YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. MyHealthChecked's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was -320.00%.

MyHealthChecked's EBITDA per Share for the six months ended in Jun. 2024 was £-0.02.


MyHealthChecked YoY EBITDA Growth Historical Data

The historical data trend for MyHealthChecked's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MyHealthChecked YoY EBITDA Growth Chart

MyHealthChecked Annual Data
Trend Dec14 Dec15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.42 6.57 134.38 -22.73 -97.06

MyHealthChecked Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 560.00 -76.60 -121.74 -45.45 -320.00

MyHealthChecked YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

MyHealthChecked's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.001-0.034)/ | 0.034 |
=-97.06 %

MyHealthChecked's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(-0.021--0.005)/ | -0.005 |
=-320.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MyHealthChecked YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of MyHealthChecked's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


MyHealthChecked Business Description

Traded in Other Exchanges
Address
East Tyndall Street, The Maltings, Cardiff, WLS, CF24 5EA
MyHealthChecked PLC is a healthcare company. The company is engaged in health diagnostics for women's fertility and specifically unexplained infertility. Its only operating segment is involved in the provision of diagnostic healthcare products. Its portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test, and Fertility App.

MyHealthChecked Headlines

No Headlines